Thursday 17 May 2007

Dr Felicity Harvey, Head of Medicines, Pharmacy and Industry Group, Simon Reeve, Head of Clinical & Cost Effectiveness in MPI, Dr Fiona Adshead, Deputy Chief Medical Officer, and Professor Mike Richards, National Cancer Director, Department of Health
Professor Sir Michael Rawlins, Chairman, and Andrew Dillon, Chief Executive, National Institute for Health and Clinical Excellence

Thursday 28 June 2007

Professor Peter C Smith, Centre for Health Economics, University of York, Professor Raymond MacAllister, Chair, Use of Medicines Committee, UCHL, and Professor Stirling Bryan, Health Services Management Centre, University of Birmingham
Ian Beaumont, Director of Press, PR and Public Affairs, Bowel Cancer UK, Dr Kiran Patel, Chairman of Trustees, South Asian Health Foundation, and Dr David Anderson, Chair, Faculty of Old Age Psychiatry, Royal College of Psychiatrists

Thursday 12 July 2007

Dame Gill Morgan, Chief Executive, NHS Confederation, Dr Tim Crayford, President, Association of Directors of Public Health, and Dr Lise Llewellyn, Chief Executive, Berkshire East PCT
Dr Richard Barker, Association of the British Pharmaceutical Industry, Eddie Gray, General Manager and Senior Vice-President, GlaxoSmithKline (GSK), and Dr David Brickwood, Vice-President, International and Government Affairs - Europe, Johnson & Johnson

Thursday 11 October 2007

Simeon Thornton, formerly of the OFT, Professor Karl Claxton, University of York, Professor Adrian Towse, Office of Health Economics, and Professor Jon Nicholl, University of Sheffield

Thursday 18 October 2007

Professor Nancy Devlin, Department of Economics, City University, and Professor John Appleby, Chief Economist, The King's Fund
Dr Beverley Hunt, Medical Director, Lifeblood: The Thrombosis Charity, Professor Roger Atkins, British Orthopaedic Association, and Dr Anita Thomas, Chair of the Chief Medical Officer's VTE Implementation Working Group
Steve Winyard, Head of Policy and Campaigns, Royal National Institute of Blind People, and Dr Rafiq Hasan, Director of Market Access, Novartis

Thursday 8 November 2007

Professor Sir Michael Rawlins, Chairman, and Andrew Dillon, Chief Executive, National Institute for Health and Clinical Excellence
Rt Hon Dawn Primarolo, a Member of the House, Minister of State for Public Health, Dr Felicity Harvey, Head of Medicines, Pharmacy and Industry Group, and Dr Sunjai Gupta, Deputy Director, Public Health Strategy, Social Marketing and Sexual Health, Department of Health